Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo

American Journal of Psychiatry

Volumn 155, Issue 6, 1998, Pages 768-773

  Pohjalainen, Tiina ^b   Rinne, Juha O ^b   Någren, Kjell ^b   Syvälahti, Erkka ^b   Hietala, Jarmo ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ADULT; AGED; ALCOHOLISM; ARTICLE; DOPAMINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALCOHOLISM; CARBON RADIOISOTOPES; CORPUS STRIATUM; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; RACLOPRIDE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; SALICYLAMIDES; SEX FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031800342     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. De Lacoste-Utamsing D, Holloway RL: Sexual dimorphism in the human corpus callosum. Science 1982; 216:1431-1432
2. Swaab DF, Fliers E: A sexually dimorphic nucleus in the human brain. Science 1985; 228:1112-1115
3. Allen LS, Gorski RA: Sexual dimorphism of the anterior commissure and massa intermedia of the human brain. J Comp Neurol 1991; 312:97-104
4. Allen LS, Gorski RA: Sex difference in the bed nucleus of the stria terminalis of the human brain. J Comp Neurol 1990; 302:697-706
5. Witelson SF, Kigar DL: Sylvian fissure morphology and asymmetry in men and women: bilateral differences in relation to handedness in men. J Comp Neurol 1992; 323:326-340
6. Gur RC, Gur RE, Orbist WD, Hungerbuhler JP, Younkin D, Rosen AD, Skolnick BE, Reivich M: Sex and handedness differences in cerebral blood flow during rest and cognitive activity. Science 1982; 217:659-661
7. Andreason PJ, Zametkin AJ, Guo AC, Baldwin P, Cohen RM: Gender-related differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Res 1994; 51:175-183
8. Volkow ND, Wang G-J, Fowler JS, Hitzemann R, Pappas N, Pascani K, Wong C: Gender differences in cerebellar metabolism: test-retest reproducibility. Am J Psychiatry 1997; 154:119-121
9. Gur RC, Mozley LH, Mozley PD, Resnick SM, Karp JS, Alavi A, Arnold SE, Gur RE: Sex differences in regional cerebral glucose metabolism during a resting state. Science 1995; 267:528-531
10. Bakan P, Putnam W: Right-left discrimination and brain lateralization: sex differences. Arch Neurol 1974; 30:334-335
11. Seeman MV: Gender differences in schizophrenia. Can J Psychiatry 1982; 27:107-112
12. Hirschfeld RMA: Psychosocial predictors of outcome in depression, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1994,pp 1113-1121
13. Brady KT, Grice DE, Dustan L, Randall C: Gender differences in substance use disorders. Am J Psychiatry 1993; 150:1707-1711
14. 2 receptor in the living human brain. Neurosci Lett 1996; 204:25-28
15. Adolfsson R, Gottfries CG, Roos BE, Winblad B: Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm 1979; 45:81-105
16. Konradi C, Kornhuber J, Sofic E, Heckers S, Riederer P, Beckmann H: Variations of monoamines and their metabolites in the human brain putamen. Brain Res 1992; 579:285-290
17. Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY: Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance. Biol Psychiatry 1997; 41:560-566
18. Di Paolo T, Bédard F, Bédard PJ: Influence of gonadal steroids on human and monkey cerebrospinal fluid homovanillic acid concentrations. Clin Neuropharmacol 1989; 12:60-66
19. Wong DF, Wagner HNJ, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JKT, Burns HD, Kuhar MJ: Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 1984; 226:1393-1396
20. Wong DF, Broussolle EP, Wand G, Villemagne V, Dannals RF, Links JM, Zacur HA, Harris J, Naidu S, Braestrup C, Wagner HN Jr, Gjedde A: In vivo measurement of dopamine receptors in human brain by positron emission tomography: age and sex differences. Ann NY Acad Sci 1988; 515:203-214
21. 11C]raclopride in man. Synapse 1995; 20:200-208
22. Seeman P: Dopamine receptors: clinical correlates, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 295-302
23. 2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 1994; 51:116-123
24. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) 1994; 116:285-290
25. Severson JA, Marcusson J, Winblad B, Finch CE: Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem 1982; 39:1623-1631
26. Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP, Bird ED, Riederer P, Jellinger K, Watanabe S, Tourtellote WW: Human brain dopamine receptors in children and aging adults. Synapse 1987; 1:399-404
27. 2 receptors. Brain Res 1990; 508:349-352
28. 11C]raclopride. J Cereb Blood Flow Metab 1993; 13:310-314
29. 11C]raclopride. Ann NY Acad Sci 1993; 695:81-85
30. 2 receptor availability in healthy human subjects. Life Sci 1995; 23:PL249-PL253
31. 18F]N-methylspiroperidol. Psychiatry Res 1996; 67:11-16
32. McGeer PL, McGeer EG, Suzuki JS: Aging and extrapyramidal function. Arch Neurol 1977; 34:33-35
33. Carlsson A, Winblad B: Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 1976; 38:271-276
34. Volkow ND, Fowler JS, Wang G-J, Logan J, Schlyer D, MacGregor R, Hitzemann R, Wolf AP: Decreased dopamine transporters with age in healthy human subjects. Ann Neurol 1994; 36:237-239
35. 123I]β-CIT SPECT. J Nucl Med 1995; 36:1175-1181
36. Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW; Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Ann Neurol 1995; 38:260-264
37. 18F]dopa uptake: absence of an aging effect. J Cereb Blood Flow Metab 1993; 13:881-888
38. Sawle GW, Colebatch JG, Shah A, Brooks DJ, Marsden CD, Frackowiak RS: Striatal function in normal aging: implications for Parkinson's disease. Ann Neurol 1990; 28:799-804
39. Martin WRW, Palmer MR, Patlak CS, Clane DB: Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989; 26:535-542
40. 3H]raclopride: implications for positron emission tomography of the human brain. Synapse 1989; 3:96-97
41. 3H]raclopride binding in the rat brain. Synapse 1991; 9:188-194
42. Dewey SL, Smith GS, Logan J, Alexoff D, Ding Y-S, King P, Pappas N, Brodie JD, Ashby CRJ: Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 1995; 15:821-829
43. 11C]raclopride in the human brain. Synapse 1994; 16:255-262
44. 2 receptors. Am J Psychiatry 1997; 154:50-55
45. 2 in schizophrenia: role of endogenous dopamine and cerebellum. Neuropsychopharmacology 1992; 7: 55-57
46. 3H]raclopride in the mouse brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 1989; 340:6-12
47. 2 dopamine receptors in monkey brain. Synapse 1997; 25:321-325
48. 2 receptor in vivo and in vitro. Biochem Biophys Res Commun 1997; 232:143-146
49. Fernandez-Ruiz JJ, Hernandez ML, De Miguel R, Ramos JA: Nigrostriatal and mesolimbic doparninergic activities were modified throughout the ovarian cycle of female rats. J Neural Transrn Gen Sect 1991; 85:223-229
50. Xiao L, Becker JB: Quantitative microdialysis determination of extracellular srriaral dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett 1994; 180:155-158
51. Crowky WR, O'Donohue TL, Jacobowitz DM: Changes in catecholamine content in discrete brain nuclei during the estrous cycle of the rat. Brain Res 1978; 147:315-326
52. Jori A, Cecchetti G: Homovanillic acid levels in rat striatum during the oestrus cycle. J Endocrinol 1973; 58:341-342
53. 3H]dopamine during the estrous cycle. Life Sci 1977; 20:1319-1332
54. Morissette M, Di Paolo T: Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 1993; 58: 16-22
55. Di Paolo T, Morissette P: Striatal dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci 1988; 43:665-672
56. Salokangas RK: Prognostic implications of the sex of schizophrenic patients. Br J Psychiatry 1983; 142:145-151
57. Seeman MV: Current outcome in schizophrenia: women vs men. Acta Psychiatr Scand 1986; 73:609-617
58. Hallonquist JD, Seeman MV, Lang M, Rector NA: Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993; 33:207-209
59. Häfner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W: Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993; 23:925-940
60. Seeman MV: Gender and the onset of schizophrenia: neurohumoral influences. Psychiatr J Univ Ottowa 1981; 6:136-138
61. Seeman MV, Lang M: The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16:185-194
62. Forrest AD, Hay AJ: The influence on sex on schizophrenia. Acta Psychiatr Scand 1972; 48:49-58
63. Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, Schlaepfer TB, Tune LE: A chart review study of late-onset and early-onser schizophrenia. Am J Psychiatry 1989; 146:1568-1574
64. Volkow ND, Wang G-J, Fowler JS, Logan J, Hitzemann R, Ding Y-S, Pappas N, Shea C, Piscani K: Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20:1594-1598